Table 5 Comparable evaluation of the obtained data and the literature review.
Drug name | Fabrication | Duration of release (h) | Antibacterial activity | Animal study | Ref. |
|---|---|---|---|---|---|
Azithromycin | Nanoformulation | 24 | – | In vivo (mice) | |
Azithromycin | Niosomal gel | 24 | Staphylococcus aureus Staphylococcus epidermidis | Ex vivo (rat abdominal skin) | |
Vancomycin | Transferosome | 24 | – | Ex vivo (wistar rat skin) | |
Azithromycin | Hollow microsphere | 12 | – | In vivo (rabbit) | |
Azithromycin | Phase inversion | 240 | Streptococcus sobrinus Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus | Ex vivo (mice skin) | This study |
